Lifeboat Foundation

The carmaker keeps the prancing horse spirit alive in its first four-door vehicle.

Italian luxury carmaker Ferrari has a long history of making luxury sports cars. So, when the company unveiled its most utilitarian vehicle in its 75-year history, CEO Benedetto Vinga had only one request, “Please don’t call it a SUV, because it isnt”, Bloomberg.

Founded in 1947, Ferrari is synonymous with cars that remain closer to the ground and faster than its competitors. Most patrons and admirers of the vehicles would rather see their favorite carmaker not release new cars than see its DNA diluted to satisfy the passenger vehicle segment.

Continue reading “Ferrari unveils its most utilitarian vehicle in over 70 years, but doesn’t call it an SUV” »

The method uses microneedles smaller than a grain of sand.

Tattooing went from a subculture to pop culture in the past decades. Tattoo artists use a mechanized needle to puncture the skin and inject ink into the dermis or second layer of skin-this is not only painful but it’s time-consuming.

The patch consists of microneedles that are each smaller than a grain of sand and are made of tattoo ink encased in a dissolvable matrix.

Continue reading “Scientists develop tattoos that are pain-free, blood-free, and self-administered” »

Many companies developed blood tests for cancer, but none of them have FDA approval so far.

The U.S. is preparing to launch trials of blood tests that can improve the detection of multiple kinds of cancer, according to a report.

Solarseven/iStock.

Continue reading “A blood test that could detect cancers early will undergo trials in the U.S.” »

He also has advice on how to bring things back on track.

Bill George, a senior fellow at Harvard Business School, thinks that Mark Zuckerberg has “really lost his way” and is slowly dragging his company Meta to failure. George made these comments while speaking to CNBC

George, a former CEO at a medical technology company himself, has spent the last two decades of his life studying leadership failures in workplaces. His recent book is a compilation of his work, where he has found that bosses who lose sight of their values and purpose are doomed to fail.

You won’t be able to blame it on your genetics anymore: with CRISPR, it’s so easy to hacn into your DNA. CRISPR technology is our future, and experiments with DNA hacking are booming. CRISPR biotechnology is not science fiction anymore, it is our very near future. Would you hack and reprogram your own DNA with CRISPR? Breaking the code of life, hacking DNA at home.

Welcome to the world of a new nature. We can now literally cut and paste DNA with the new CRISPR technology. There is a revolutionary development going on that will have major consequences for humans, plants and animals. The new biotechnology is here.

Continue reading “Hack your DNA with CRISPR — VPRO documentary” »

Researchers from the Max Planck Institute for Polymer Research have developed a drug that disrupts the adaptability of cancer cells!

Abstract: in situ assembly of platinum(ii)-metallopeptide nanostructures disrupts energy homeostasis and cellular metabolism.

Continue reading “A Breakthrough Cancer Treatment” »

A team of scientists is using the tools offered by the HBP’s digital research infrastructure EBRAINS to address one of the oldest enigmas in neuroscience: the dichotomy of brain structure and function.

Every human brain is different. But even with structural differences, individual brains function in a similar way. In other words, there are functional brains based on completely different configurations. At the same time, a structural change may cause loss of function in one brain, but have no consequences in another individual. Or a drug cocktail may be efficient for one patient, and have no effects for another.

Cancer is one of the major global public health problems and is caused by abnormal cell proliferation. A plant immune protein has recently been found to enable widespread anti-tumor responses by alleviating micro-RNA

Ribonucleic acid (RNA) is a polymeric molecule similar to DNA that is essential in various biological roles in coding, decoding, regulation and expression of genes. Both are nucleic acids, but unlike DNA, RNA is single-stranded. An RNA strand has a backbone made of alternating sugar (ribose) and phosphate groups. Attached to each sugar is one of four bases—adenine (A), uracil (U), cytosine ©, or guanine (G). Different types of RNA exist in the cell: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA).

The study population comprised 6,245,282 older adults (age ≥65 years) who had medical encounters with healthcare organizations between 2/2/2020–5/30/2021 and had no prior diagnosis of Alzheimer’s disease. The population was divided into two cohorts: 1) COVID-19 cohort (n = 410,748)— contracted COVID-19 between 2/2/2020–5/30/2021; 2) non-COVID-19 cohort (n = 5,834,534)— had no documented COVID-19 but had medical encounters with healthcare organizations between 2/2/2020–5/30/2021. The status of Alzheimer’s disease and COVID-19 were based on the International Classification of Diseases (ICD-10) diagnosis codes and laboratory tests (details in the Supplementary Material).

We examined risks for new diagnosis of Alzheimer’s disease in COVID-19 and non-COVID-19 cohorts in all older adults, three age groups (65–74, 75–84, ≥85), and three racial/ethnic groups (Black, White, and Hispanic). Cohorts were propensity-score matched (1:1 using a nearest neighbor greedy matching) for demographics, adverse socioeconomical determinants of health including problems with education, occupational exposure, physical, social and psychosocial environment, and known risk factors for Alzheimer’s disease [13] (details in the Supplementary Material). Kaplan-Meier analysis was used to estimate the probability of new diagnosis of Alzheimer’s disease within 360 days after the COVID-19 diagnosis. Cox’s proportional hazards model was used to compare matched cohorts using hazard ratios and 95% confidence intervals. All statistical tests were conducted within the TriNetX Advanced Analytics Platform at significance set at p < 0.05 (2-sided).